Boni E Elewski (B Elewski, B E Elewski, Boni Elewski)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Topics

Hidradenitis Suppurativa

Top Venues

The British journal of dermatology

Journal of the European Academy of Dermatology and Venereology : JEADV

Proceedings of the National Academy of Sciences of the United States of America

Dermatology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Bruce E Strober, Hervé Bachelez, Jeffrey Crowley, Boni E Elewski, Melinda J Gooderham, Martin Alan Menter, Robert Strohal, Michael M Chen, Tianshuang Wu, Tianyu Zhan, Huzefa Photowala, April W Armstrong
Efficacy of long-term risankizumab treatment for moderate-to-severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitless trial). Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Bruce E Strober, Hervé Bachelez, Jeffrey Crowley, Boni E Elewski, Melinda J Gooderham, Martin Alan Menter, Robert Strohal, Michael M Chen, Tianshuang Wu, Tianyu Zhan, Huzefa Photowala, April W Armstrong
Efficacy of long-term risankizumab treatment for moderate-to-severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitless trial). Journal of the European Academy of Dermatology and Venereology : JEADV 38 (5) (2024)
Ali Elabbasi, Ahmed Kadry, Warren S Joseph, Boni E Elewski, Mahmoud A Ghannoum
Transungual Penetration and Antifungal Activity of Prescription and Over-the-Counter Topical Antifungals: Ex Vivo Comparison. Dermatology and therapy (2024)
Bruce E Strober, Hervé Bachelez, Jeffrey Crowley, Boni E Elewski, Melinda J Gooderham, Martin Alan Menter, Robert Strohal, Michael M Chen, Tianshuang Wu, Tianyu Zhan, Huzefa Photowala, April W Armstrong
Efficacy of long-term risankizumab treatment for moderate-to-severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitless trial). Journal of the European Academy of Dermatology and Venereology : JEADV 38 (5) (2024)
Mahendra P Kashyap, Bharat K Mishra, Rajesh Sinha, Lin Jin, Nilesh Kumar, Kayla F Goliwas, Jessy S Deshane, Boni E Elewski, Craig A Elmets, Mohammad Athar, M Shahid Mukhtar, Chander Raman
NK and NKT cells in the pathogenesis of Hidradenitis suppurativa: Novel therapeutic strategy through targeting of CD2. bioRxiv : the preprint server for biology (2023)
Lin Jin, Yunjia Chen, Suhail Muzaffar, Chao Li, Carlos A Mier-Aguilar, Jasim Khan, Mahendra P Kashyap, Shanrun Liu, Ritesh Srivastava, Jessy S Deshane, Tim M Townes, Boni E Elewski, Craig A Elmets, David K Crossman, Chander Raman, Mohammad Athar
Epigenetic switch reshapes epithelial progenitor cell signatures and drives inflammatory pathogenesis in hidradenitis suppurativa. Proceedings of the National Academy of Sciences of the United States of America 120 (49) (2023)
Kristian Reich, Xenophon Baraliakos, Laura C Coates, Boni E Elewski, Weibin Bao, Torben Kasparek, Corine Gaillez, Effie Pournara, Maher Aassi, Chiara Perella, Alice B Gottlieb
Secukinumab demonstrates high and sustained efficacy in nail psoriasis: post hoc analysis from phase III trials in patients with psoriatic arthritis. The British journal of dermatology 187 (3) (2022)
Jonathan Ian Silverberg, D Toth, Thomas Bieber, A F Alexis, Boni E Elewski, Andrew E Pink, Dirk-Jan Hijnen, T N Jensen, B Bang, C K Olsen, Azra Kurbasic, Stephan Weidinger, null null
Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial. The British journal of dermatology 184 (3) (2021)
Boni E Elewski
A call for antifungal stewardship. The British journal of dermatology 183 (5) (2020)
Sandra M Pena, Allen S W Oak, A M Smith, T T Mayo, Boni E Elewski
Topical crisaborole is an efficacious steroid-sparing agent for treating mild-to-moderate seborrhoeic dermatitis. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (12) (2020)
Andrew Blauvelt, C Leonardi, Boni E Elewski, J J Crowley, L C Guenther, Melinda J Gooderham, R G Langley, Ronald B Vender, Andreas Pinter, C E M Griffiths, Y Tada, H Elmaraghy, R G Lima, G Gallo, L Renda, Russel T Burge, S Y Park, B Zhu, Kim A Papp, null null
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trial. The British journal of dermatology 184 (6) (2020)
Boni E Elewski, S Brand, T Degenhardt, S Curelop, R Pollak, R Schotzinger, A Tavakkol
A phase II, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of VT-1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail. The British journal of dermatology 184 (2) (2020)
E Chen, M Ghannoum, Boni E Elewski
Treatment-resistant tinea corporis, a potential public health issue. The British journal of dermatology 184 (1) (2020)
Kristian Reich, J Sullivan, P Arenberger, S Jazayeri, Ulrich Mrowietz, Matthias Augustin, Boni E Elewski, R You, P Regnault, J A Frueh
Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5-year results from the randomized placebo-controlled TRANSFIGURE study. The British journal of dermatology 184 (3) (2020)
Boni E Elewski
Rosacea treatment: a patient-centric approach. The British journal of dermatology 182 (5) (2019)
C A Shaw, L C S Kole, Boni E Elewski
Association of psoriasis/psoriatic arthritis with inflammatory bowel disease influences management strategy. Journal of the European Academy of Dermatology and Venereology : JEADV 33 (11) (2019)
Elizabeth N Ergen, S L Donaldson, M S Stratton, P G Pavlidakey, Boni E Elewski
Image Gallery: Molluscum contagiosum-like facial lesions in a patient with a renal transplant: deep dermatophytosis due to Trichophyton rubrum. The British journal of dermatology 178 (5) (2019)